In the BioHarmony Drug Report Database

"Preview" Icon

Secnidazole

Solosec (secnidazole) is a small molecule pharmaceutical. Secnidazole was first approved as Solosec on 2017-09-15. It is used to treat bacterial vaginosis in the USA. Solosec’s patent is valid until 2035-09-04 (FDA).

 

Trade Name

 

Solosec
 

Common Name

 

secnidazole
 

ChEMBL ID

 

CHEMBL498847
 

Indication

 

bacterial vaginosis
 

Drug Class

 

Antiprotozoal substances (metronidazole type)

Image (chem structure or protein)

Secnidazole structure rendering